Related Experiment Video
Updated: Jul 11, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Tuberculosis prevention: current strategies and future directions.
Anca Vasiliu1, Leonardo Martinez2, Rishi K Gupta3
1Department of Pediatrics, Baylor College of Medicine, Global TB Program, Houston, TX, USA.
Preventing tuberculosis requires a multifaceted strategy including vaccination, infection detection, and accessible preventive treatments. Addressing social determinants and advancing research are key to reducing the global tuberculosis burden.
Area of Science:
- Infectious Diseases
- Public Health
- Immunology
Background:
- Tuberculosis (TB) infection affects a quarter of the global population, with a significant percentage progressing to active disease.
- Preventing TB is crucial for controlling the epidemic and achieving World Health Organization (WHO) END-TB Strategy goals.
- Understanding the spectrum from latent infection to active TB is vital for effective prevention strategies.
Purpose of the Study:
- To provide a comprehensive review of current evidence and recent advancements in tuberculosis prevention.
- To summarize state-of-the-art updates on TB prevention in diverse settings and high-risk populations.
Main Methods:
- Literature review and synthesis of findings on tuberculosis prevention strategies.
- Overview of current research developments in TB prevention.
Main Results:
- Focus on Mycobacterium bovis Bacille-Calmette-Guérin (BCG) vaccination and novel vaccine candidates.
- Review of diagnostic tests for latent Mycobacterium tuberculosis infection.
- Analysis of available tuberculosis preventive treatment regimens and recommendations for various settings.
Conclusions:
- Effective global TB prevention necessitates a comprehensive approach, including addressing social determinants of health.
- Improved access to TB detection and novel, short-course preventive treatment regimens is essential.
- Continued collaboration and innovative research are critical for developing new diagnostics, vaccines, and treatments for all populations.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...